Color Code
Brown

Serotyping of Pneumococcal Disease

976
infectious disease
Serotyping of Pneumococcal Disease
India
To develop a test with TaqMan array cards to evaluate all pneumococcal serotypes causing meningitis.
Emory University (Bill & Melinda Gates Foundation)
CDC’s National Center for Immunization and Respiratory Diseases; Emory University Rollins School of Public Health; National Institute for Communicable Diseases; Bill & Melinda Gates Foundation

Dissolving Microneedle Patch for MR Vaccination

969
infectious disease
Dissolving Microneedle Patch for MR Vaccination
United States of America
To support the development of a dissolving microneedle patch for measles and rubella (MR) vaccination.
UNICEF
CDC’s National Center for Immunization and Respiratory Diseases; CDC’s Center for Global Health; Georgia Institute of Technology; Micron Biomedical

Pneumococcal Conjugate Vaccine Impact Review

961
infectious disease
Pneumococcal Conjugate Vaccine Impact Review
United States of America
To provide a comprehensive literature search on Pneumococcal Conjugate Vaccine impact on immunogenicity, nasopharyngeal colonization, otitis media, pneumonia, invasive pneumococcal disease and mortality.
Johns Hopkins University (Bill & Melinda Gates Foundation)
CDC’s National Center for Immunization and Respiratory Diseases; Johns Hopkins Bloomberg School of Public Health; International Vaccine Access Center; World Health Organization

GAVI Alliance Partner Engagement Framework

971
infectious disease
GAVI Alliance Partner Engagement Framework
Afghanistan
Bangladesh
Burkina Faso
Democratic Republic of the Congo
Cameroon
Ethiopia
Gambia
Haiti
Indonesia
India
Cambodia
Mali
Myanmar
Mozambique
Nigeria
Nepal
Pakistan
Rwanda
Senegal
Uganda
Viet Nam
Zambia
Zimbabwe
To strengthen vaccine-preventable disease surveillance platforms to maximize their capacity to measure burden of disease and to monitor the impact of vaccines. Activities include improving immunization data quality; evaluating impact and implementation of vaccines (including oral cholera, rubella, and HPV); improving the quality and planning of measles and rubella campaigns; and strengthening surveillance for vaccine preventable diseases (meningitis, diphtheria and pertussis, intussusception).
GAVI
CDC's National Center for Immunization and Respiratory Diseases

Increasing the Supply of Organs for Georgians

934
infectious disease
Increasing the Supply of Organs for Georgians
Georgia, USA
United States of America
To increase the number of organs that are used for transplant in Georgia and the U.S. by using advanced analytics methods for quantifying the risk and comparing survival of receiving a transplant versus remaining on the wait list, and embed these methods into easy-to-use multilingual decision support tools to assist doctors and patients in their decision-making. Overall, this research will lead to a comprehensive plan for increasing organ transplants and saving lives in Georgia and across the country.
Georgia Tech (Carlos and Marguerite Mason Trust)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

David J. Sencer CDC Museum AIDS History Project

892
AIDS ribbon
David J. Sencer CDC Museum AIDS History Project
United States of America
To document CDC's role during the early years of the AIDS epidemic by gathering information and documents from CDC scientists, public health advisors and other staff who worked during the early years of the epidemic.
Abbott Laboratories; Gilead Sciences
CDC’s Office of the Associate Director for Communication; Emory University

TB Clinical Research Database and Drug Monitoring

796
infectious disease
TB Clinical Research Database and Drug Monitoring
United States of America
To abstract data from medical records of tuberculosis patients to study modeling the pharmacokinetics of second-line anti-tuberculosis drugs.
University of Florida (Bill & Melinda Gates Foundation)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Subscribe to Infectious Disease